Friday 25 January 2019

Market Overview of Swine and Avian Influenza Drug Development Market in Global Industry 2019

ResearchMoz presents professional and in-depth study of "Swine and Avian Influenza Drug Development Pipeline Review, 2017".

This report provides an overview of the Swine and Avian Influenza pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for influenza A virus, subtypes H5N1 and H1N1, and features dormant and discontinued projects.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1394152

H5N1 is a type of influenza virus that causes a highly infectious, severe respiratory disease in birds called avian influenza. This virus can spread to humans. There are a total of 63 products in development for this indication, by 47 companies and six academic institutions.

H1N1 Infection also called as swine flu is a new kind of flu in humans. It's caused by the contagious H1N1 influenza virus. There are a total of 99 products in development for this indication, by 67 companies and 14 academic institutions.

In both types of influenza, the most common molecular target being studied is hemagglutinin, by a considerable margin. However, a number of both human and viral proteins are also under active development.

Scope

- Which companies are the most active within each pipeline?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy

- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

View Complete TOC with tables & Figures @ https://www.researchmoz.us/swine-and-avian-influenza-drug-development-pipeline-review-2017-report.html/toc

Table of Contents

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 7

2 Introduction 8
2.1 Swine and Avian Influenza Report Coverage 8
2.2 Influenza A Virus, H5N1 Subtype Infections Overview 8
2.3 Influenza A Virus, H1N1 Subtype Infections Overview 8

3 Therapeutics Development 9
3.1 Influenza A Virus, H5N1 Subtype Infections 9
3.2 Influenza A Virus, H1N1 Subtype Infections 18

4 Therapeutics Assessment 30
4.1 Influenza A Virus, H5N1 Subtype Infections 30
4.2 Influenza A Virus, H1N1 Subtype Infections 36
5 Companies Involved in Therapeutics Development 43

5.1 Influenza A Virus, H5N1 Subtype Infections 43
5.2 Influenza A Virus, H1N1 Subtype Infections 58

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1394152

6 Dormant Projects 81
6.1 Influenza A Virus, H5N1 Subtype Infections 81
6.2 Influenza A Virus, H1N1 Subtype Infections 86

7 Discontinued Products 90
7.1 Influenza A Virus, H5N1 Subtype Infections 90

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

No comments:

Post a Comment